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Abstract
Background: Traditionally, conventional mechanical ventilation (CMV) and intubation was the preferred
route commonly employed by physicians to support patients with acute respiratory failure. However,
mechanical ventilation via endotracheal intubation (ETI) may lead to injury of the trachea and may also result
in ventilator-associated nosocomial pneumonia. As a consequence, there has been growing interest in NPPV
support because of its promising role in avoiding intubation and associated complications.
Purpose: To assess the effectiveness of non-invasive positive pressure ventilation (NPPV) vs. conventional
mechanical ventilation (CMV) on the need for intubation, length of hospital ICUs stay, mortality rates, and
complications on adult patients with acute respiratory failure (ARF).
Study Design: To select for randomize control trials (RCT), randomized prospective studies, only trials done
in the ICU, trials that compare NPPV vs. CMV, articles with a Jadad score of two or greater.
Methods: A multi-method approach was used to identify relevant research for this review. A computerized
exhaustive literature search using the following search engines: Medline, Ovid, Cinahl, and Cochrane from the
years 1990 to 2009. Bibliographies of all selected articles and review articles that included information on
NPPV and CMV were reviewed also. Included were English language studies on adult subjects. Once
irrelevant studies had been excluded individual review of the titles and abstracts were conducted. Searches
were run numerous times with different combinations of key terms to eliminate irrelevant materials that didn’t
address the clinical question and selected PICO.
Results: The three included studies are all randomized studies comparing the effectiveness of NPPV via a face
mask vs. CMV via ETI in hospital ICU setting. These three studies are all in agreement on the effect of NPPV
reducing the need for intubation with p-values that are statistically significant. Results of hospital ICU length
of stay, mortality rates and complications, there exists apparent inconsistencies among the studies, for
example, in the study by Honrubia et al and Conti et al, both indicated findings of non-significant differences
between NPPV or CMV in hospital length of ICU stay, mortality, and complications. However, in the study
by Antonelli et al, the NPPV group had statistically significant findings of decreased length of ICU stay with
p=0.002, and fewer complications with p=0.02 respectively.
Conclusion: There is promising evidence in the literature supporting the use of NPPV in adult patients with
ARF especially those with acute exacerbation of COPD. At present, with the limited studies published in
“randomized controlled trials”, addressing the clinical question, despite promising data from uncontrolled
studies, it is clearly necessary to pursue further information in the form of randomized, controlled trials to
definitively assess the effectiveness and safety of noninvasive positive pressure ventilation in the setting of
acute respiratory failure due to other causes as well.
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Abstract   
 
Background:  Traditionally, conventional mechanical ventilation (CMV) and intubation was the 
preferred route commonly employed by physicians to support patients with acute respiratory failure. 
However, mechanical ventilation via endotracheal intubation (ETI) may lead to injury of the trachea and 
may also result in ventilator-associated nosocomial pneumonia. As a consequence, there has been 
growing interest in NPPV support because of its promising role in avoiding intubation and associated 
complications.  
 
Purpose:  To assess the effectiveness of non-invasive positive pressure ventilation (NPPV) vs. 
conventional mechanical ventilation (CMV) on the need for intubation, length of hospital ICUs stay, 
mortality rates, and complications on adult patients with acute respiratory failure (ARF).  
 
Study Design:  To select for randomize control trials (RCT), randomized prospective studies, only trials 
done in the ICU, trials that compare NPPV vs. CMV, articles with a Jadad score of two or greater.  
1) Population: adult patients with acute respiratory failure (ARF) in the Intensive care unit (ICU)  
2) Intervention: the use of non-invasive positive pressure ventilation (NPPV)  
3) Comparison:  to conventional mechanical ventilation (CMV)  
4) Outcome: need for intubation, length of ICUs stay, mortality rate, and complications  
 
Methods:  A multi-method approach was used to identify relevant research for this review. A 
computerized exhaustive literature search using the following search engines: Medline, Ovid, Cinahl, 
and Cochrane from the years 1990 to 2009. Bibliographies of all selected articles and review articles that 
included information on NPPV and CMV were reviewed also. Included were English language studies 
on adult subjects. Once irrelevant studies had been excluded individual review of the titles and abstracts 
were conducted. Searches were run numerous times with different combinations of key terms to 
eliminate irrelevant materials that didn’t address the clinical question and selected PICO.  
 
Results:  The three included studies are all randomized studies comparing the effectiveness of NPPV via 
a face mask vs. CMV via ETI in hospital ICU setting. These three studies are all in agreement on the 
effect of NPPV reducing the need for intubation with p-values that are statistically significant. Results of 
hospital ICU length of stay, mortality rates and complications, there exists apparent inconsistencies 
among the studies, for example, in the study by Honrubia et al and Conti et al, both indicated findings of 
non-significant differences between NPPV or CMV in hospital length of ICU stay, mortality, and 
complications. However, in the study by Antonelli et al, the NPPV group had statistically significant 
findings of decreased length of ICU stay with p=0.002, and fewer complications with p=0.02 
respectively. 
 
Conclusion:  There is promising evidence in the literature supporting the use of NPPV in adult patients 
with ARF especially those with acute exacerbation of COPD. At present, with the limited studies 
published in “randomized controlled trials”, addressing the clinical question, despite promising data 
from uncontrolled studies, it is clearly necessary to pursue further information in the form of 
randomized, controlled trials to definitively assess the effectiveness and safety of noninvasive positive 
pressure ventilation in the setting of acute respiratory failure due to other causes as well. 
 
Keywords:  The following search terms were used: acute respiratory failure, BiPAP, conventional 
mechanical ventilation, intubation, noninvasive mechanical ventilation, and randomized control trial.
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The Effect of Non-Invasive Positive Pressure Ventilation (NPPV) via a Face Mask vs. Conventional 
Mechanical Ventilation (CMV) via Endotracheal Intubation (ETI) in Adult Patients with Acute 
Respiratory Failure (ARF): A Systematic Review of the Literature 
 
Introduction 
 The purpose of this systematic review is to assess the effectiveness of non-invasive positive 
pressure ventilation (NPPV) vs. conventional mechanical ventilation (CMV) on the need for intubation, 
length of hospital ICUs stay, and mortality rates on adult patients with acute respiratory failure (ARF).  
Respiratory failure (RF) is a condition in which the respiratory system fails in one or both of its gas-
exchanging functions; oxygenation of mixed venous blood and elimination of carbon dioxide.1 The 
respiratory system consists of two parts: (a) the gas-exchanging organ (lung) and (b) the ventilatory 
pump; chest wall, respiratory muscles, respiratory controllers, and the pathways that connect the central 
controllers with the respiratory muscles. Failure of the gas-exchanging organ causes type I RF, this is 
characterized by hypoxemia with normocapnia or hypocapnia. Failure of the pump, causes type II RF 
(ventilatory failure) the hallmark of which is hypercapnia.2 The distinction between type I and II RF 
must not be viewed as rigid, since (a) type I failure may be complicated by respiratory pump failure and 
hypercapnia, and (b) type II failure may be complicated by severe hypoxemia due to secondary 
pulmonary parenchymal processes (eg, pneumonia, atelectasis, pulmonary edema), or vascular disorders 
like pulmonary embolism.1 In ARF, regardless of the presence or absence of hypercapnia, treatment of 
hypoxemia is the first priority especially in patients with type II RF, because hypoxemia kills quickly, 
while hypercapnia kills more slowly. At the same time, when appropriate, measures to improve alveolar 
ventilation should be taken.3 Type III, or perioperative RF, is predominantly the result of atelectasis, 
although fluid overload, bronchospasm, airway secretions, and preexisting lung disease can also 
contribute. The end result may be hypoxemic respiratory failure with increased shunt, ventilatory failure, 
or both. Type IV RF is seen in patients who are in shock or in hypoperfusion states, without associated 
pulmonary problems. In a way it is a subtype of type II RF, resulting from greatly increased work of 
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breathing in conjunction with reduced perfusion, and therefore oxygen delivery, by the diaphragm and 
other respiratory muscles.  
 Respiratory failure is further classified as acute RF (ARF) and chronic RF (CRF). Respiratory 
failure in its acute form is a direct threat to life, which can develop within minutes or hours, while, in its 
chronic form it can affects both the quality of life and the expected survival of involved patients. Critical 
care can be lifesaving for patients with ARF while interventions incorporating medical technology can 
ameliorate the consequences of CRF and its exacerbations. This review will only be focusing on acute 
respiratory failure.  
 Data on the incidence of ARF in the community are hard to come by. The disorder may be 
caused by a multitude of underlying disease entities, may have widely varying severity, prognosis, 
varying treatment strategies, and may be treated in a great variety of settings: emergency department, 
medical unit, and intensive care unit.  According to Conti et al4ARF was defined as the presence of all 
the following criteria: a) respiratory acidosis with pH values lower than 7.32, b) bicarbonate levels 
higher than 30mEq/L, c) hypoxemia with Pa02 values lower than 45 while breathing room air, d) 
respiratory rate higher than 30 breaths/min, and e) history of worsening dyspnea of less than 2 weeks 
duration.4 
 Traditionally, conventional mechanical ventilation (CMV) and intubation was the preferred route 
commonly employed by physicians to support patients with acute respiratory failure. However, 
endotracheal intubation (ETI) via mechanical ventilation may lead to injury of the pharynx, larynx, and 
trachea. 5 Mechanical ventilation via an endotracheal tube may also result in ventilator-associated 
nosocomial pneumonia.5  Other complications include: barotrauma, upper-airway injury, and prolonged 
ICU and hospital stay. As a consequence, there has been growing interest in non-invasive ventilatory 
support because of its promising role in avoiding intubation and associated complications.6 According to 
Poponick et al, “over the past decade non-invasive positive pressure ventilation (NPPV) has gained in 
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popularity”. 7 This term refers to positive pressure ventilation delivered through a noninvasive interface 
such as a nasal mask, facemask, or nasal plugs, rather than an invasive interface with an endotracheal 
tube, or tracheostomy.  
 The use of NPPV to treat patients with ARF may be lifesaving, as it decreases the load on 
respiratory muscles, changes the pattern of breathing, and results in oxygen treatment without further 
increasing arterial carbon dioxide tension (PaCO2 ), and reverses hypercapnia within 1–4 hours. The 
application of NPPV to appropriate patients with type 2 RF can avert intubation and has been shown by 
prior studies to improve survival mainly because of decreased rates of nosocomial infection. Non-
invasive positive pressure ventilation should not replace invasive mechanical ventilation in severely 
compromised patients, but as a measure that if used in a timely fashion can prevent further deterioration 
of the patient and can avoid intubation altogether.  
 The use of NPPV is recommended for relaxed, non-combative patients and doesn't generally 
require sedation. Some complications include gastric distention, aspiration pneumonia, hypotension, and 
pneumothorax.8  For these reasons, NPPV shouldn't be used on patients who have facial traumas or have 
undergone recent facial surgery, who have excessive secretions for risk of aspiration, are experiencing 
gastrointestinal bleeding or don't have the ability to protect their own airways. Other complications of 
NPPV are typically minor and include injury to tissues where the mask makes contact with the skin of 
the face. This risk is especially true for older patients who typically have friable skin. Indications and 
contraindications for the application of NPPV in patients with ARF appear in (Table II).  
 BiPAP can be administered both with nasal and full-face masks. The nasal mask is usually well 
tolerated because it causes less claustrophobia and discomfort. It allows eating, drinking and 
expectorating. Conversely, a facial mask is preferable in severe respiratory failure, because dyspneic 
patients breathe through the mouth in order to bypass resistance in the nasal passages, and mouth 
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opening during nasal mask ventilation results in air leakage and decreased effectiveness.9 Masks are 
firmly secured with elastic straps to the face in order to avoid air leaks and consequent malfunction. 
 Tracing back into history, the concept of non-invasive mechanical ventilation first evolved with 
negative-pressure ventilation. Woillez, in 1876 developed the first workable iron lung. Then, in 1889, 
Alexander Graham Bell designed and built a prototype of iron lung. On October 12, 1928, Drinker was 
first to used a non-invasive negative-pressure ventilation machine on a child with respiratory failure 
resulting in success and popularized the iron lung. The iron lung was in high demands during the polio 
epidemics of the 1930s, 1940s, and 1950s and was the first non-invasive mechanical ventilator of its 
time. Then the biphasic cuirass ventilation (BCV) was developed as a refinement of the iron lung 
ventilator. With time, more refinements from the original iron lung concept took place; during the 1940s 
to 1960s the intermittent positive pressure breathing (IPPB) machines was developed and used. The 
newer bi-level positive airway pressure (BiPAP) machine is a descendant of the IPPB and is a form of 
NPPV now use on patients with ARF. 
 There are multiple reasons why BiPAP might improve breathing and should be used. It would 
improve alveolar ventilation and gas exchange, counteract intrinsic positive end expiratory pressure 
(PEEP), decrease pre-load and after-load, improve lung compliance, and decrease the work of 
breathing.10  BiPAP delivers inspiratory positive airway pressure (IPAP) and expiratory positive airway 
pressure (EPAP) at a different level (IPAP>EPAP) to result in bi-level positive airway pressure 
ventilation.10 In another words, BiPAP delivers continuous positive airway pressure (CPAP), but also 
senses when an inspiratory effort is being made and delivers a higher pressure during inspiration. When 
flow stops, the pressure returns to the CPAP level. The positive pressure wave during inspirations 
unloads the diaphragm, which aides in decreasing the work of breathing.                                                                                                                                                
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Methods 
Search strategy 
 
 A multi-method approach was used to identify relevant research for this review. A computerized 
exhaustive literature search using the following search engines: Medline, Ovid, Cinahl, and Cochrane 
from the years 1990 to 2009. The following search terms were used: acute respiratory failure, BiPAP, 
conventional mechanical ventilation, intubation, noninvasive mechanical ventilation, and randomized 
control trial. Bibliographies of all selected articles and review articles that included information on 
NPPV and CMV were reviewed also. Included were English language studies on adult subjects. Once 
irrelevant studies had been excluded individual review of the titles and abstracts were conducted. 
Searches were run numerous times with different combinations of key terms to eliminate irrelevant 
materials that didn’t address the clinical question and selected PICO.  
Study selection  
 Specific inclusions were 1) Population: adult patients with acute respiratory failure (ARF) in the 
Intensive care unit (ICU); 2) Intervention: the use of non-invasive positive pressure ventilation (NPPV); 
3) Comparison:  to conventional mechanical ventilation (CMV); 4) Outcome: need for intubation, length 
of ICUs stay, mortality rate, and complications. Additional inclusions were to select for randomize 
control trials (RCT), randomized prospective studies, only trials done in the ICU, trials that compare 
NPPV vs. CMV, articles with a Jadad score of two or greater.  
 The following criteria were used to identify articles for exclusion: pediatric patient, animal 
studies, non-English articles, retrospective studies, sample surveys, observational study, CPAP only 
studies, studies which included patients who failed intubation and were then placed on BiPAP, studies of 
patients using NPPV as a weaning modality, studies which did not implement both NPPV and CMV. 
From a narrowed down pool of 25 articles, after applying the exclusion criteria, three articles met the 
criteria and addressed the clinical question. 
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Assessment of quality/Validity 
 The selected randomized studies were independently reviewed using the Jadad score: A 
numerical score between 0-5 is assigned as rough measures of study design/reporting quality (0 being 
weakest and 5 being strongest).11 This number is based on a well-established, validated scale developed 
by Jadad et al.11 The selected studies earned Jadad score of 2 or greater. A critical appraisal form for 
articles focusing on therapy was also used to assess the quality and validity of each individual study. The 
appraisal form was retrieved through Pacific University’s blackboard, student resources link. 
Results 
Study description 
  
 The three included studies are all randomized studies comparing the effectiveness of NPPV via a 
face mask vs. CMV via ETI in hospital ICU setting. These trials were conducted not in the USA, but in 
countries like Spain, Rome, and Italy. Publications are in English from credited sources like CHEST, 
Intensive Care Med, and The New England Journal of Medicine. One study was conducted as a 
randomized multi-center control trial at the ICU of seven different hospitals; the other two studies were 
conducted at a single center, University hospital, ICU. One study looked at adults with ARF from 
multiple factors; the second study looked mainly at chronic obstructive pulmonary disease 
 (COPD) patients; and the third study looked at patients with hypoxemic acute respiratory failure.  
Outcomes 
 
 Honrubia et al12  conducted a multi-center randomized controlled trial from seven hospital ICUs, 
screening for patients with ARF from various causes who meet the criteria for mechanical ventilation. 
Between November 1999 and September 2001, 64 patients were recruited; 31 were assigned to non-
invasive mechanical ventilation, and 33 were assigned to CMV. 12 The noninvasive group received 
ventilation through a face mask in pressure support mode plus, positive end-expiratory pressure ie. 
BiPAP; the conventional group received ventilation through a tracheal tube.12 
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 Honrubia et al12  reported, in the non-invasive group, 58% of patients were intubated, vs. 100% 
in the conventional group (RRR, 43%; p<0.001). In the ICU death occurred in 23% and 39% (p=0.09) 
respectively and complications occurred in 52% and 70% (p=0.07) in the noninvasive and conventional 
groups. There were no differences in length of hospital stay. The study found a non-significant trend of 
reduction in ICU and hospital mortality, together with fewer complications during the ICU stay. 12 
 Conti et al4 conducted a randomized prospective study comparing NPPV with CMV via ETI in a 
group of patients with COPD who failed standard medical treatment in the emergency ward and met 
predetermined criteria for ventilatory support. The study was conducted at a university hospital 13-bed 
general ICU. Between October 1996 and January 1999, all non-intubated COPD patients with ARF 
caused by acute exacerbation admitted to La Sapienza University Hospital emergency ward, were 
screened for the study. Patients who meet predetermined criteria for ventilatory support were admitted to 
the ICU to receive mechanical ventilation. After ICU admission, 49 patients were randomly assigned, 23 
patients were randomized to NPPV and 26 to conventional ventilation.  
 Conti et al4  reported that both NPPV and conventional ventilation significantly improved gas 
exchanges. The two groups were similar in length of ICU stay, in number of days on mechanical 
ventilation, in overall complications, in ICU mortality, and in hospital mortality. In the NPPV group 11 
patients, 48%, avoided intubation, survived, and had a shorter duration of ICU stay than intubated 
patients. One year following hospital discharge the NPPV group had fewer patients readmitted to the 
hospital 65% vs. 100% of the conventional group.  
 Antonelli et al13  conducted a prospective randomized trial of 64 patients with hypoxemic acute 
respiratory failure who meet entry criteria and required mechanical ventilation. The trial is of 
noninvasive positive-pressure ventilation as compared with endotracheal intubation with conventional 
mechanical ventilation. Antonelli et al13  reported results within the first hour of ventilation, 20 of 32 
patients, (62%) of the noninvasive-ventilation group and 15 of  32  patients, (47%) of the conventional 
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ventilation group had an improved ratio of the partial pressure of arterial oxygen to the fraction of 
inspired oxygen (PaO2:FiO2) (P=0.21). Ten patients in the non-invasive ventilation group subsequently 
required endotracheal intubation. Twenty-three patients in the non-invasive ventilation group, (72%) vs. 
17 patients in the conventional ventilation group, (53%) survived their stay in the intensive care unit 
(odds ratio, 0.4; 95 percent confidence interval, 0.1 to 1.4; P=0.19); 22 patients in the non-invasive 
ventilation group and 16 patients in the conventional ventilation group were discharged from the 
hospital. More patients in the conventional ventilation group had serious complications than in the 
noninvasive group (66% vs. 38%, P=0.02) and had pneumonia or sinusitis related to the endotracheal 
tube (31% vs. 3%, P=0.003). Among the survivors, patients in the noninvasive ventilation group had 
shorter periods of ventilation (P=0.006) and shorter stays in the intensive care unit (P=0.002). 
Discussion 
 This systematic review of the effectiveness of non-invasive positive pressure ventilation vs. 
conventional mechanical ventilation in patients with acute respiratory failure, suggests that NPPV does 
have beneficial effects on the survival and decreases the need for endotracheal intubation in the studied 
population. From those articles reviewed, there are strong indications that patients with acute 
exacerbation of COPD had the most benefit from NPPV, compared to other causes of ARF. Non-
invasive positive pressure ventilation should not replace invasive mechanical ventilation in severely 
compromised patients, but as a measure that if used in a timely fashion can prevent further deterioration 
of the patient and can avoid intubation altogether.  
 These three studies are all in agreement on the effect of NPPV reducing the need for intubation 
with p-values that are statistically significant. In the study by Honrubia et al, 13 patients out of 31 (42%) 
in the NPPV group avoided intubation, in the study by Conti et al, 11 of 23 (48%) avoided intubation, 
and Antonelli et al reported 22 of 32 (69%) successfully avoided intubation. With these studies 
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averaging around 50% of the participants who were able to avoid intubation and survived their hospital 
stay is a promising fact.  
 It is also important to note in a long term study report by Conti et al4 on patients with COPD, 
NPPV is comparable to CMV in terms of survival if NPPV is used after the failure of medical treatment. 
However, in situations where NPPV fails this does not result in a worse outcome. One year following 
hospital discharge the NPPV group had fewer patients readmitted to the hospital 65% vs. 100% of the 
conventional group.  
 Regarding results of hospital ICU length of stay, mortality rates and complications, there exists 
apparent inconsistencies among the studies, for example, in the study by Honrubia et al12 and Conti et 
al4, both indicated findings of non-significant differences between NPPV or CMV in hospital length of 
ICU stay, mortality, and complications. However, in the study by Antonelli et al13 the NPPV group had 
statistically significant findings of decreased length of ICU stay with p=0.002, and fewer complications 
with p=0.02 respectively. 
Strength of study 
 The strength of a quantitative systematic review includes a comprehensive search strategy, 
objective study selection criteria, and validity assessment of the primary studies.14An extensive search 
using computerized databases, bibliographies of selected and review articles, was conducted to avoid 
publication and language bias, making it less likely to affect the results. All studies examined in this 
systematic review, had similar exclusion criteria for contraindications to NPPV, such as: respiratory 
arrest, hemodynamic instability, facial deformities, high risks for aspiration, septic shock, and/or deep 
coma. However, there was some variability within the inclusion criteria among studies, but not within 
the individual study.   
 To maintain a non-biased assessment of the quality/validity of individualized selected study with 
focus on the clinical question and PICO.  The first article reviewed is by Honrubia et al12 a RCT with 64 
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subjects. This study implemented a computer-based, pseudorandom number generator to randomize the 
selected subjects. Allocations were issued using opaque, sealed, and numbered envelopes.12 
 Factors which gave this study strength are: at the start, patients were divided into two similar 
sample size groups, the consent form given and signed, inclusion and exclusion criteria were well 
described, indications of the types of mechanical ventilation and settings were addressed, and CMV 
patients were informed about sedation and a record made. Also, follow up was conducted, the study 
included clear easy to follow tables and figures, and study limitations were mentioned and explained.12 
Overall, this study received high marks for the Jadad score of three, as well as the clinical appraisal form 
for quality and validity. Points for blinding were not given because it was not applicable. 
 In the study by Conti and colleagues, a randomized prospective study, was conducted of 49 
patients after a pool of 94 patients was assessed. Patients were randomized into two groups; the 
assignment was made with sealed envelopes. At the start of the study, the two sample groups were close 
in size. Factors which increased strength in this study were its one year follow up reporting long term 
benefits with the usage of NPPV in COPD patients. This study, also, defined ARF with its inclusion 
criteria and included a long list of exclusion criteria applied to recruit the selected patients. The study 
also mentioned that a consent form was given and signed, indicated the ventilator interventions and 
settings used, and addressed, complications from patients within the study groups. Sedation was 
implemented on patients in the CMV group with information given as to the type of drug used, dose, 
route, and management. Overall, this study also received high marks on the Jadad score of three. No 
points were given for blinding. The clinical appraisal form was used to assess for quality and validity.    
 In the study by Antonelli and colleagues, 64 ARF patients were randomized into two groups of 
either NPPV or CMV. Factors which gave this study strength were: the mentioning of consent form 
being given and signed, clear inclusion and exclusion criteria, and the indication of the types of 
mechanical ventilation and settings used to provide similar ventilatory support among the two groups. 
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The starting sample sizes were equal with similar conditions causing ARF. The study did mention that 
sedation was used in the CMV coupled group with the type of drug, dose, route, and management. 
Justifications of the causes of complications and events leading to death were shown in a table form. 
Overall, this study received average marks for the Jadad score of two, no points for blinding, and the 
clinical appraisal form was used for assessment of quality and validity.   
Limitation of study 
 Honrubia et al12recognized that the limitation of their study was the small sample size. They 
believed it would decrease the ability to detect differences in mortality and complications. One of the 
setbacks they experienced was that the study was stopped before achieving the planned sample size due 
to decreased enrollment.  
 According to Keenan et al14 there exists a body of literature reporting the experience of experts in 
NPPV, consisting of carefully conducted, prospective, but uncontrolled, case series. The results reported 
by these authors suggest that noninvasive positive pressure ventilation may be useful for patients 
presenting with respiratory failure from quite a diverse range of etiologies. However, only a few of those 
studies were about both NPPV and CMV. The same problems were seen during this recent literature 
search for studies comparing NPPV vs. CMV. There exist, very limited data on RCT for this subject.   
 In the study by Antonelli et al13factors which made this study weak are: the lack of detail about 
follow up, it lacked a limitation section to their study, and the process of randomizing patients into the 
two groups was not described even though they claimed to have done so. Another non-significant 
weakness of this study was it was not a controlled trial. 
 There appears to be a lacking of a universal name and abbreviation for “non-invasive positive 
pressure ventilation”, the term used in this systematic review. Many researchers use a different name and 
abbreviation in their studies for non-invasive positive pressure ventilation. For example; non-invasive 
mechanical ventilation (NIMV); Bi-level positive airway pressure (BiPAP); and non-invasive positive 
Page 18 of 22 
 
pressure ventilation (NIPPV) vs. NPPV without the “I”. This difference might be due to geographical 
locations and/or to the time in which the studies were conducted. These terms all appear to refer to the 
same concept. To make things even more confusing, BiPAP and CPAP are both types of non-invasive 
ventilator (NIV). However, NIV is not the same as NPPV because of the lack of bi-level pressure, like in 
BiPAP. Therefore, CPAP was not included in this systematic review because; the clinical focus was on 
NPPV. This makes it hard for readers to follow along, but not knowing the difference could result in 
inappropriate data selections and altered review results. 
Conclusion   
 There is promising evidence in the literature supporting the use of NPPV in adult patients with 
ARF especially those with acute exacerbation of COPD. Non-invasive positive pressure ventilation 
reduces the need for intubation in patients with ARF from different causes. Regarding results of hospital 
ICU length of stay, mortality rates and complications, there are apparent inconsistencies among the 
studies. At present, with the limited studies published in “randomized controlled trials”, addressing the 
clinical question, despite promising data from uncontrolled studies, it is clearly necessary to pursue 
further information in the form of randomized, controlled trials to definitively assess the effectiveness 
and safety of noninvasive positive pressure ventilation in the setting of acute respiratory failure due to 
other causes as well. 
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Table I.  Summary Matrix of selected studies  
Author/  
Title 
Yr.  
published 
Patients/  
Population 
Intervention Comparison Outcome(s) Study type Validity 
(Jadad 
score) 
Journal 
Honrubia et al 
 
Noninvasive 
vs 
Conventional 
Mechanical 
Ventilation in 
Acute 
Respiratory 
Failure: A 
Multicenter, 
Randomized 
Controlled 
Trial 
Dec. 2005 Sixty-four 
adult 
patients 
with Acute 
respiratory 
failure 
(ARF) 
Non-invasive 
mechanical 
ventilation 
(NIMV) via 
face mask 
Conventional 
mechanical 
ventilation 
(CMV) via 
endotracheal 
tube 
Reduction in 
the need for 
intubation and 
therapeutic 
intervention in 
patients with 
ARF from 
different 
causes. 
Multicenter 
Randomized 
controlled 
trial (RCT) 
      3 CHEST 
 
 
         
Antonelli et al 
 
A 
Comparison 
of Non-
invasive 
Positive 
Pressure 
Ventilation 
(NPPV) and 
Conventional 
Mechanical 
Ventilation in 
Patients with 
ARF 
Aug. 1998 Sixty-four 
adult 
patients 
with 
hypoxemic 
ARF who 
required 
mechanical 
ventilation 
NPPV via 
face mask 
CMV + 
endotracheal 
intubation 
(ETI) 
Decreasing 
complications, 
and ICU length 
of stay. 
Prospective 
randomized 
trial (PRT) 
       2 New 
England 
Journal of 
Med 
         
Conti et al 
 
Non-invasive 
vs. 
conventional 
mechanical 
ventilation in 
patients with 
chronic 
obstructive 
pulmonary 
disease 
(COPD) after 
failure of 
medical 
treatment in 
the ward: a 
randomized 
trial 
Aug. 2002 Forty-nine 
adult 
patients 
with COPD 
who failed 
standard 
medical 
treatment in 
the 
emergency 
department 
and were 
admitted to 
the 
intensive 
care unit 
(ICU) 
NPPV via 
face mask 
CMV via 
(ETI) 
Gas exchange, 
length of ICU 
stay, days on 
mechanical 
ventilation, 
complications, 
and mortality 
rate 
Randomized 
prospective 
study (RPS) 
      3 Intensive 
Care Med 
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Table II. Indications and contraindications for the application of NPPV in patients with ARF  
Indications Contraindications 
Respiratory acidosis with pH< 7.32 Cardiac/Respiratory arrest 
Bicarbonate levels > 30mEq/L Severe encephalopathy 
Hypoxemia with Pa02 < 45 while breathing room air Severe hemodynamic instability  
Respiratory rate > 30 breaths/min Gastrointestinal bleeding/recent surgery 
Increase dyspnea, medium severity < 2 weeks Acute coronary syndrome (unstable angina, MI) 
PaC02 < 45mmHg Impaired consciousness/ coma  
Pa02/Fi02 < 200 Facial trauma/ deformity 
Alert with GCS > 13 Recent upper airway surgery/ airway stenosis 
Patent upper airway High risk for aspiration/inability to clear secretions 
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